We further investigated the relationship between GPER1 and tumour-infiltrating lymphocytes (TILs), immunoinhibitors, immunostimulators, major histocompatibility complex (MHC) molecules, chemokines and chemokine receptors via the TISDB. This evidence concerns the gene GPER1 and neoplasm.